Collectively, the findings presented here suggest that BITC inhibits breast tumor progression and provide in vitro as well as in vivo evidence for the involvement of LKB1 as an important mediator, and uncover a novel mechanism of BITC action through p53 and p73 activation. The gene discussed is TP53; the disease is breast neoplasm.